Target intelligence / Profile preview

RNF139 divergent transcript (RNF139-DT)

Target
RNF139-DT
Molecular classification
Long non-coding RNA (lncRNA), Other
01

Overview

RNF139 divergent transcript (RNF139-DT), also known as RNF139-AS1 or RNF139 antisense RNA 1 (head to head), is a long non-coding RNA gene. It is classified as part of the lncRNA family and does not encode a protein. Associations reported include glioma susceptibility 1, but there is no established therapeutic relevance, known molecular function, or interaction with drugs reported in major databases[4][1][5][6]. The transcript is not listed as a part of any known Mendelian disease phenotype and its precise biological function remains uncharacterized[5][6].\n\nClarification: This target is a non-coding RNA and is not a receptor, enzyme, transporter, or other traditional drug target. There are no known interacting drugs, biomarkers, mechanisms of action, or established disease roles beyond genetic association studies[4][5][6]. There are no major issues with the spelling or identification of this target, but its biological and therapeutic roles are incompletely characterized.

Other names
RNF139-AS1RNF139 antisense RNA 1 (head to head)RNF139 divergent transcript
02

Biological functions

unknownOther
03

Disease associations

Glioma susceptibility 1

Beyond the preview

Go deeper on RNF139 divergent transcript (RNF139-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNF139 divergent transcript (RNF139-DT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call